Sage Journals: Discover world-class research

Retricted access

Research article

First published 2006-11

Differing immunogenic potentials of interferon beta preparations in multiple sclerosis patients

C Gneiss, P Tripp, F Reichartseder [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2001-12

A prospective,open-label treatment trial to compare the effect of IFNβ-1a (Avonex®),IFNβ-1b (Betaseron®),and glatiramer acetate (Copaxone®) on the relapse rate in relapsing-remitting multiple sclerosis: results after 18 months of therapy

Omar A Khan, Alexandros C Tselis, John A Kamholz [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2005-04

Contrast-enhanced MRI lesions during treatment with interferonβ-1b predict increase in T1 black hole volume in patients with relapsing-remitting multiple sclerosis

K Morgen, A LT Crawford, R D Stone [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2003-08

Necrotizing skin lesions and NA Bs development in a multiple sclerosis patient treated with IFNβ 1b

Federica Casoni, Elisa Merelli, Roberta Bedin [...]

Multiple Sclerosis Journal

Free access

Research article

First published 2005-4

Effects of Interferon Beta,Cyclophosphamide and Azathioprine on Cytokine Profile in Patients with Multiple Sclerosis

R. Totaro, A. Passacantando, T. Russo [...]

International Journal of Immunopathology and Pharmacology

Retricted access

Research article

First published 2006-06

Persistence of neutralizing antibodies after discontinuation of IFNβ therapy in patients with relapsing-remitting multiple sclerosis

Bodil Petersen, Klaus Bendtzen, Nils Koch-Henriksen [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2007-5

Clinical relevance of anti-drug antibodies with interferon beta-1b therapy in multiple sclerosis

M. Cantillon, I. Antonijevic

Multiple Sclerosis Journal

Retricted access

Research article

First published 2006-02

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with NAb

P Barbero, M Bergui, E Versino [...]

Multiple Sclerosis Journal

Free access

Research article

First published 2006-1

Safety and Tolerability of a ‘Refrigeration-free’ Formulation of Interferon Beta-1b - Results of a Double-blind,Multicentre,Comparative Study in Patients with Relapsing-Remitting or Secondary Progressive Multiple Sclerosis

K Baum, Mannitol Formulation Study Group

Journal of International Medical Research

Retricted access

Research article

First published 2016-03

An Albumin-Free Formulation for Escherichia coli -Derived Interferon Beta-1b with Decreased Immunogenicity in Immune Tolerant Mice

Mohadeseh Haji Abdolvahab, Ahmad Fazeli, Mazda Radmalekshahi [...]

Journal of Interferon & Cytokine Research

Search results